| Defibrotide shows efficacy in the prevention of sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: A retrospective study Y Chalandon, AC Mamez, F Giannotti, Y Beauverd, C Dantin, E Mahne, ... Transplantation and Cellular Therapy 28 (11), 765. e1-765. e9, 2022 | 6 | 2022 |
| Evaluation of Disease Risk Comorbidity Index after Allogeneic Stem Cell Transplantation in a Cohort with Patients Undergoing Transplantation with In Vitro Partially T Cell … Y Beauverd, S Morin, M Nabergoj, C Stephan, CDR Ortiz, AC Mamez, ... Transplantation and Cellular Therapy 27 (1), 67. e1-67. e7, 2021 | 2 | 2021 |
| Multiple myeloma in the elderly: impact of a geriatric assessment B Bruno, C De Ramon Ortiz, S Ligozat, K Samii, T Chevalley Revue Medicale Suisse 15 (670), 2032-2038, 2019 | 1 | 2019 |
| Remission of relapsed/refractory classical Hodgkin lymphoma induced by brentuximab vedotin and pembrolizumab combination after allogeneic hematopoietic stem cell … F Giannotti, C De Ramon Ortiz, F Simonetta, S Morin, C Bernardi, ... Frontiers in Immunology 15, 1360275, 2024 | | 2024 |
| How to integrate CD19 specific chimeric antigen receptor T cells with other CD19 targeting agents in diffuse large B‐cell lymphoma? C de Ramon Ortiz, S Wang, A Stathis, F Bertoni, T Zenz, U Novak, ... Hematological oncology 42 (1), e3237, 2024 | | 2024 |
| Low Plasma Levels of Hyaluronic Acid Might Rule Out Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation C De Ramón Ortiz, R Justo Sanz, Y Beauverd, K Humala, ... Disease Markers 2023, 2023 | | 2023 |
| Treatment and outcomes of patients with post-transplant lymphoproliferative disorder: a single centre experience C Ortiz, K Samii, A Avram, AC Mamez, S Masouridi-Levrat, Y Chalandon, ... SWISS MEDICAL WEEKLY 152, 39S-40S, 2022 | | 2022 |
| Outcome of patients with multiple myeloma receiving allogeneic hematopoietic stem cell transplantation in the pre-car t cell era C Ortiz, D Ramon, F Giannotti, AC Mamez, Y Beauverd, S Morin, TA Tran, ... BONE MARROW TRANSPLANTATION 57 (SUPPL 1), 323-324, 2022 | | 2022 |
| The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients … Y Beauverd, S Morin, C Stephan, C De Ramon Ortiz, M Fabra Urdiola, ... Bone Marrow Transplantation 56 (9), 2284-2286, 2021 | | 2021 |
| TREATMENT AND OUTCOMES OF PATIENTS WITH POST‐TRANSPLANT LYMPHOPROLIFERATIVE DISORDER: A SINGLE CENTRE EXPERIENCE C de Ramon Ortiz, K Samii, K Hadaya, A Avram, Y Beauverd Hematological Oncology 39, 2021 | | 2021 |
| Impact of Donor-recipient Sex Mismatch in Patients Receiving Partial T-cell Depleted Allogeneic Stem Cell Transplantation for Hematological Malignancy: A Retrospective … M Nabergoj, M Anastasiou, S Morin, Y Beauverd, C Stephan, CDR Ortiz, ... BONE MARROW TRANSPLANTATION 55 (SUPPL 1), 676-676, 2020 | | 2020 |
| Efficacy and Toxicity of Ruxolitinib in Patients with steroid-resistant Acute and Chronic graft-versus-host Disease after Hematopoietic Cell Transplantation A Petropoulou, M Nabergoj, AC Mamez, S Morin, E Mahne, CDR Ortiz, ... BONE MARROW TRANSPLANTATION 55 (SUPPL 1), 334-335, 2020 | | 2020 |
| Validation of Disease Risk Comorbidity Index (DRCI) for Overall Survival after Allogeneic Stem Cell Transplantation (HSCT) With Partially T-cell Depleted GRAFT Y Beauverd, S Morin, M Nabergoi, C Stephan, CDR Ortiz, AC Mamez, ... BONE MARROW TRANSPLANTATION 55 (SUPPL 1), 401-402, 2020 | | 2020 |
| The AML EBMT Cytogenetic Risk Score for Acute Myeloid Leukaemia (AML) Is Prognostic for Outcomes of Allogeneic Stem Cell (HSCT) Y Beauverd, S Morin, M Nabergoj, C Stephan, CDR Ortiz, AC Mamez, ... Blood 136, 19-20, 2020 | | 2020 |
| Impact of Different T Cell Depletion Protocols on Immune Reconstitution Following Allogeneic Hematopoietic Stem Cell Transplantation A Pradier, A Petitpas, AC Mamez, F Giannotti, S Morin, E Mahne, ... Blood 136, 43-44, 2020 | | 2020 |
| Impact of T-cell depletion on outcome in patients undergoing allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia S Morin, Y Beauverd, M Nabergoj, F Giannotti, C Dantin, A Pradier, ... BONE MARROW TRANSPLANTATION 54, 147-148, 2019 | | 2019 |
| Outcome of patients with chronic myeloid leukemia transplanted with HLA-identical sibling donor and partial T-cell depletion. a single center experience with a very long follow-up SM Levrat, S Morin, F Giannotti, C Dantin, A Pradier, TA Tran, T Longval, ... BONE MARROW TRANSPLANTATION 54, 205-206, 2019 | | 2019 |
| Comparison between two reduced intensity conditioning regimens in patients with a myeloid malignancy: A single center experience comparing FB2 with flumel M Nabergoj, AC Mamez, S Morin, CR Ortiz, C Dantin, A Pradier, TA Tran, ... BONE MARROW TRANSPLANTATION 54, 220-220, 2019 | | 2019 |
| Outcome of patients with chronic myeloid leukemia transplanted with HLA-identical sibling donor and partial T-cell depletion. A single center experience with a very long follow-up S Masouridi-Levrat, S Morin, F Giannotti, C Dantin, A Pradier, TA Tran, ... SWISS MEDICAL WEEKLY 149, 3S-3S, 2019 | | 2019 |
| ROLE OF THE SERUM MARKERS OF ENDOTHELIAL INJURY IN THE DIAGNOSIS OF SINUSOIDAL BLOCKAGE SYNDROME IN PATIENTS SUBJECTED TO TPH C De Ramon Ortiz, R Justo Sanz, E Monzon Manzano, M Fabra Urdiola, ... HAEMATOLOGICA 102, 66-66, 2017 | | 2017 |
